SALE
市場調查報告書

栓塞療法的全球市場:至2025年的各適應症,各產品,各類型,各終端用戶,各地區預測及機會

Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 934748
出版日期 內容資訊 英文 112 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

栓塞療法的全球市場:至2025年的各適應症,各產品,各類型,各終端用戶,各地區預測及機會 Global Embolotherapy Market By Indication, By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 112 Pages
簡介

全球栓塞療法市場,預計根據慢性疾病的發生率的上升,患者族群的增加,醫療費的劇增等的要素,對在預測期間內大幅度的年複合成長率成長。預計再加上栓塞療法設備的迅速的技術進步到2025年也推動市場成長。

本報告提供全球栓塞療法市場調查,各地區市場展望,市場動態,主要趨勢,競爭情形等資訊,以及策略性建議。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球市場的影響

第4章 摘要整理

第5章 顧客的迴響

第6章 全球市場的展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 適應症(癌症,消化器官疾病,神經疾病,末稍血管疾病,泌尿科及腎臟病)
    • 各產品(栓塞劑(栓塞線圈,栓塞插頭系統,液體栓塞劑,微球,可拆球囊),支援設備(微導管,導管導引線))
    • 各類型(化學栓塞術,放射線栓塞術,動脈栓塞術,並用)
    • 終端用戶(醫院,診所,門診病人手術中心,其他)
    • 各公司(2019)
    • 各地區
  • 市場魅力指數

第7章 亞太地區市場展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 各適應症
    • 各栓塞劑
    • 各類型
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國市場的展望
    • 印度市場展望
    • 日本市場展望
    • 韓國市場展望
    • 新加坡市場展望
    • 澳洲市場展望

第8章 歐洲市場展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 各適應症
    • 各栓塞劑
    • 各類型
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國市場展望
    • 德國市場展望
    • 英國市場展望
    • 義大利市場展望
    • 俄羅斯市場展望
    • 西班牙市場展望

第9章 北美市場展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 各適應症
    • 各栓塞劑
    • 各類型
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國市場的展望
    • 墨西哥市場展望
    • 加拿大市場展望

第10章 南美市場展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 各適應症
    • 各栓塞劑
    • 各類型
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西市場展望
    • 阿根廷市場展望
    • 哥倫比亞市場展望

第11章 中東、非洲市場展望

  • 市場規模與預測
    • 以金額、數量為準
  • 市場佔有率與預測
    • 各適應症
    • 各栓塞劑
    • 各類型
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:國家分析
    • 南非市場展望
    • 沙烏地阿拉伯市場展望
    • UAE 市場展望

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與趨勢

第14章 競爭情形

  • 競爭展望
  • 企業簡介(主要企業)
    • Abbott Laboratories
    • ABK Biomedical Inc
    • Acandis GmbH
    • AngioDynamics Inc
    • Becton Dickinson and Company
    • Boston Scientific Corporation
    • Cook Medical
    • Guerbet
    • Imbiotechnologies Ltd.
    • Johnson & Johnson
    • KANEKA
    • Medtronic
    • Meril Life Sciences Pvt. Ltd.
    • Merit Medical Systems
    • Merit Medical Systems, Inc.
    • Penumbra, Inc.
    • Simbionix USA Corporation
    • Sirtex Medical Limited
    • Stryker Corporation
    • Terumo Corporation

第15章 策略性推薦事項

第16章 免責聲明

目錄
Product Code: 4666

Global embolotherapy market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.

Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.

The global embolotherapy market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.

The global embolotherapy market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the global embolotherapy market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.

Major players operating in the global embolotherapy market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the global embolotherapy market.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of global embolotherapy market.
  • To classify and forecast global embolotherapy market based on indication, product, type, end-user and regional distribution.
  • To identify drivers and challenges for global embolotherapy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global embolotherapy market.
  • To conduct pricing analysis for global embolotherapy market.
  • To identify and analyze the profile of leading players operating in global embolotherapy market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global embolotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience

  • Embolotherapy hospitals/clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to embolotherapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope

In this report, global embolotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Indication:

Cancer

Gastrointestinal Disorders

Neurological Diseases

Peripheral Vascular Disease

Urological & Nephrological Disorders

  • Market, By Product:

Embolic Agents

  • Embolic Coils
  • Embolic Plug Systems
  • Liquid Embolic Agents
  • Microspheres
  • Detachable Balloons

Support Devices

  • Microcatheters
  • Guidewires
  • Market, By Type:

Chemoembolization

Radioembolization

Arterial Embolization

Combination

  • Market, By End-User:

Hospitals

Clinics

Ambulatory Surgical Centers

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global embolotherapy market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Embolotherapy Market

4. Executive Summary

5. Voice of Customer

6. Global Embolotherapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
    • 6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
    • 6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
    • 6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Embolotherapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Indication
    • 7.2.2. By Embolic agents
    • 7.2.3. By Types
    • 7.2.4. By End-User
    • 7.2.5. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Asia-Pacific: Country Analysis
    • 7.4.1. China Embolotherapy Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Indication
        • 7.4.1.2.2. By Embolic agents
        • 7.4.1.2.3. By Types
        • 7.4.1.2.4. By End-User
    • 7.4.2. India Embolotherapy Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Indication
        • 7.4.2.2.2. By Embolic agents
        • 7.4.2.2.3. By Types
        • 7.4.2.2.4. By End-User
    • 7.4.3. Japan Embolotherapy Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Indication
        • 7.4.3.2.2. By Embolic agents
        • 7.4.3.2.3. By Types
        • 7.4.3.2.4. By End-User
    • 7.4.4. South Korea Embolotherapy Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Indication
        • 7.4.4.2.2. By Embolic agents
        • 7.4.4.2.3. By Types
        • 7.4.4.2.4. By End-User
    • 7.4.5. Singapore Embolotherapy Market Outlook
      • 7.4.5.1. Market Size & Forecast
        • 7.4.5.1.1. By Value
      • 7.4.5.2. Market Share & Forecast
        • 7.4.5.2.1. By Indication
        • 7.4.5.2.2. By Embolic agents
        • 7.4.5.2.3. By Types
        • 7.4.5.2.4. By End-User
    • 7.4.6. Australia Embolotherapy Market Outlook
      • 7.4.6.1. Market Size & Forecast
        • 7.4.6.1.1. By Value
      • 7.4.6.2. Market Share & Forecast
        • 7.4.6.2.1. By Indication
        • 7.4.6.2.2. By Embolic agents
        • 7.4.6.2.3. By Types
        • 7.4.6.2.4. By End-User

8. Europe Embolotherapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Indication
    • 8.2.2. By Embolic agents
    • 8.2.3. By Types
    • 8.2.4. By End-User
    • 8.2.5. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. Europe: Country Analysis
    • 8.4.1. France Embolotherapy Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Indication
        • 8.4.1.2.2. By Embolic agents
        • 8.4.1.2.3. By Types
        • 8.4.1.2.4. By End-User
    • 8.4.2. Germany Embolotherapy Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Indication
        • 8.4.2.2.2. By Embolic agents
        • 8.4.2.2.3. By Types
        • 8.4.2.2.4. By End-User
    • 8.4.3. United Kingdom Embolotherapy Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Indication
        • 8.4.3.2.2. By Embolic agents
        • 8.4.3.2.3. By Types
        • 8.4.3.2.4. By End-User
    • 8.4.4. Italy Embolotherapy Market Outlook
      • 8.4.4.1. Market Size & Forecast
        • 8.4.4.1.1. By Value
      • 8.4.4.2. Market Share & Forecast
        • 8.4.4.2.1. By Indication
        • 8.4.4.2.2. By Embolic agents
        • 8.4.4.2.3. By Types
        • 8.4.4.2.4. By End-User
    • 8.4.5. Russia Embolotherapy Market Outlook
      • 8.4.5.1. Market Size & Forecast
        • 8.4.5.1.1. By Value
      • 8.4.5.2. Market Share & Forecast
        • 8.4.5.2.1. By Indication
        • 8.4.5.2.2. By Embolic agents
        • 8.4.5.2.3. By Types
        • 8.4.5.2.4. By End-User
    • 8.4.6. Spain Embolotherapy Market Outlook
      • 8.4.6.1. Market Size & Forecast
        • 8.4.6.1.1. By Value
      • 8.4.6.2. Market Share & Forecast
        • 8.4.6.2.1. By Indication
        • 8.4.6.2.2. By Embolic agents
        • 8.4.6.2.3. By Types
        • 8.4.6.2.4. By End-User

9. North America Embolotherapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Indication
    • 9.2.2. By Embolic agents
    • 9.2.3. By Types
    • 9.2.4. By End-User
    • 9.2.5. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. North America: Country Analysis
    • 9.4.1. United States Embolotherapy Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Indication
        • 9.4.1.2.2. By Embolic agents
        • 9.4.1.2.3. By Types
        • 9.4.1.2.4. By End-User
    • 9.4.2. Mexico Embolotherapy Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Indication
        • 9.4.2.2.2. By Embolic agents
        • 9.4.2.2.3. By Types
        • 9.4.2.2.4. By End-User
    • 9.4.3. Canada Embolotherapy Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Indication
        • 9.4.3.2.2. By Embolic agents
        • 9.4.3.2.3. By Types
        • 9.4.3.2.4. By End-User

10. South America Embolotherapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Indication
    • 10.2.2. By Embolic agents
    • 10.2.3. By Types
    • 10.2.4. By End-User
    • 10.2.5. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. South America: Country Analysis
    • 10.4.1. Brazil Embolotherapy Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Indication
        • 10.4.1.2.2. By Embolic agents
        • 10.4.1.2.3. By Types
        • 10.4.1.2.4. By End-User
    • 10.4.2. Argentina Embolotherapy Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Indication
        • 10.4.2.2.2. By Embolic agents
        • 10.4.2.2.3. By Types
        • 10.4.2.2.4. By End-User
    • 10.4.3. Colombia Embolotherapy Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Indication
        • 10.4.3.2.2. By Embolic agents
        • 10.4.3.2.3. By Types
        • 10.4.3.2.4. By End-User

11. Middle East and Africa Embolotherapy Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value & Volume
  • 11.2. Market Share & Forecast
    • 11.2.1. By Indication
    • 11.2.2. By Embolic agents
    • 11.2.3. By Types
    • 11.2.4. By End-User
    • 11.2.5. By Country
  • 11.3. Market Attractiveness Index
  • 11.4. MEA: Country Analysis
    • 11.4.1. South Africa Embolotherapy Market Outlook
      • 11.4.1.1. Market Size & Forecast
        • 11.4.1.1.1. By Value
      • 11.4.1.2. Market Share & Forecast
        • 11.4.1.2.1. By Indication
        • 11.4.1.2.2. By Embolic agents
        • 11.4.1.2.3. By Types
        • 11.4.1.2.4. By End-User
    • 11.4.2. Saudi Arabia Embolotherapy Market Outlook
      • 11.4.2.1. Market Size & Forecast
        • 11.4.2.1.1. By Value
      • 11.4.2.2. Market Share & Forecast
        • 11.4.2.2.1. By Indication
        • 11.4.2.2.2. By Embolic agents
        • 11.4.2.2.3. By Types
        • 11.4.2.2.4. By End-User
    • 11.4.3. UAE Embolotherapy Market Outlook
      • 11.4.3.1. Market Size & Forecast
        • 11.4.3.1.1. By Value
      • 11.4.3.2. Market Share & Forecast
        • 11.4.3.2.1. By Indication
        • 11.4.3.2.2. By Embolic agents
        • 11.4.3.2.3. By Types
        • 11.4.3.2.4. By End-User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Players Profiled (Leading Companies)
    • 14.2.1. Abbott Laboratories
    • 14.2.2. ABK Biomedical Inc
    • 14.2.3. Acandis GmbH
    • 14.2.4. AngioDynamics Inc
    • 14.2.5. Becton Dickinson and Company
    • 14.2.6. Boston Scientific Corporation
    • 14.2.7. Cook Medical
    • 14.2.8. Guerbet
    • 14.2.9. Imbiotechnologies Ltd.
    • 14.2.10. Johnson & Johnson
    • 14.2.11. Kaneka Corporation
    • 14.2.12. Medtronic
    • 14.2.13. Meril Life Sciences Pvt. Ltd.
    • 14.2.14. Merit Medical Systems
    • 14.2.15. Merit Medical Systems, Inc.
    • 14.2.16. Penumbra, Inc.
    • 14.2.17. Simbionix USA Corporation
    • 14.2.18. Sirtex Medical Limited
    • 14.2.19. Stryker Corporation
    • 14.2.20. Terumo Corporation

15. Strategic Recommendations

16. About Us & Disclaimer